embarking on the robotic odyssey - india - nanavati …speciality hospital mumbai uro-oncology is a...

8
BLK Super Speciality Hospital Accredited by JCI BLK Super Speciality Hospital Pusa Road, New Delhi-110005 (India) 24-Hour Helpline: 011- 3040 3040 Email: [email protected] [email protected] www.blkhospital.com Nanavati Super Speciality Hospital Swami Vivekanand Road, Vile Parle West Mumbai, Maharashtra-400056 (India) 24-Hour Helpline: +91-22-26267500 [email protected] www.nanavatihospital.org OCTOBER 2018 | ISSUE 31 THE ROBOTIC ODYSSEY Embarking on FIXED FOR GOOD THE RIGHT WAY P4 P9

Upload: others

Post on 05-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

BLK Super Speciality HospitalAccredited by JCI

BLK Super Speciality HospitalPusa Road, New Delhi-110005 (India)

24-Hour Helpline: 011- 3040 3040Email: [email protected]

[email protected]

Nanavati Super Speciality HospitalSwami Vivekanand Road, Vile Parle WestMumbai, Maharashtra-400056 (India)24-Hour Helpline: +91-22-26267500marketing@nanavatihospital.orgwww.nanavatihospital.org

OCTOBER 2018 | ISSUE 31

THE ROBOTICODYSSEY

Embarking on

FIXED FOR GOOD THE RIGHT WAYP4 P9

Page 2: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

EMBARKING ON THE ROBOTIC ODYSSEY

by Dr. Surender Dabas

6 - 7

FIXED FOR GOOD by Dr. Deepak Chaudhary

& Dr. Shiv Chouksey

4

ENHANCED MANAGEMENT by Dr. Vivek Venkat

5

BID FAREWELL TO PAINby Dr. Puneet Girdhar & Dr. Rohit Gulati

8

BACK TO BASICSby Dr. Sudeep Sarkar

10

THE RIGHT WAYby Dr. Purushottam

Vashistha

9

GOOD TO KNOW FACTS by Dr. Salil S. Bendre

11

BLK & NANAVATI IN NEWS

14 - 15

EVENTS ANDACTIVITIES

12 - 13

FROM THE DIRECTOR’S DESK

02 Radiant Life Care | Newsletter | October 2018 03BLK, New Delhi | Nanavati, Mumbai

Dear Reader,

The introduction of advanced technologies in healthcare, effectively adopted in a wide range of medical procedures, is one of the best ways to achieve unmatched precision. Enhanced precision, vision, dexterity and control enables surgeons to perform a variety of delicate and complex surgical procedures and bring forth safer and favourable results. BLK Super Speciality Hospital is proud to present the highly advanced Robotic system and offer our patients the benefits of this technology. It is also a privilege for us to have one of the most experienced surgeon in the field of Robotics, Dr. Surender Dabas, leading our Robotic Surgical Oncology program. Since the launch of the program, the Robotic Surgery team has already performed more than 20 Robotic surgeries including the case we have featured as the cover story of this month's Pulse edition.

For the cover story, we have this interesting case of a 77-year-old patient with poorly differentiated Adenocarcinoma of the stomach for which he underwent a Robotic Total Gastrectomy and Roux-en-Y Esophagojejunostomy at BLK Super Speciality Hospital. This edition also includes, among other stories, the intriguing case of a 64-year-old man with facial swelling who regained his normal facial symmetry after a successful maxillectomy with reconstruction. There is also a case where a 51-year-old man with a history of recurrent left shoulder dislocation got a lasting solution after receiving a successful Arthroscopic Revision Bankart Repair with Remplissage at BLK.

You will also find the story of 32-year-old patient with distension of the abdomen, suffering from jaundice, who after a successful Liver Transplant is now leading a healthy life, thanks to the expert interventions of our doctors at Nanavati, Mumbai. On the informative piece front, there is one on how Spinal Cord Stimulators are helping patients suffering from pains of the neuropathic origin by masking the pain signals before reaching the brain and another one on Tuberculosis of the Lymph Node. You will also like the piece on the advances in the field of Uro-oncology; how newer and more advanced techniques and technologies are adopted to offer enhanced results.

I would like to share my sincere gratitude with the supporters and contributors of this newsletter. Your continued support has been of valuable motivation for us, and we hope to receive the same in days to come. If you have any other stories or articles which you feel is fit for this newsletter, do send them to us at our mail [email protected].

Stay Healthy, Stay Happy!

CONTENT SHIKHA GIRGLA MAMTA SINGH

Nanavati Super Speciality HospitalMumbai, Editorial Team

PRAJAKTI SHIRSEKARSHYAM SHIRSEKAR

EDITOR-IN-CHIEF PARUL CHHABRA

CREATIVE CONCEPT PARUL CHHABRA SHIKHA GIRGLA

SUNIL KUMAR

DESIGN & VISUALISATION

SUNIL KUMAR

CONTENTS

Dr. Mradul KaushikDirector - Operations & Planning BLK Super Speciality Hospital New Delhi

Page 3: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

Bankart Repair or Latarjet procedure would subject to intra-operative Arthroscopic findings.

On Arthroscopic evaluation, the glenoid bone loss was found to be less than 25% but with an engaging Hill Sachs lesion; hence, the Latarjet procedure was not done, and an Arthroscopic Revision Bankart Repair with Remplissage was done to address the bipolar bone loss. The patient’s post-operative course and rehabilitation were uneventful. The patient was gradually gaining near-normal activity.

The major advantages of an Arthroscopic approach, in this case, was preserving the corocoid other than the regular benefits like lesser surgical morbidity, post-operative pain, the reduced cost of an outpatient setting, improved cosmesis and an easier if not shorter rehabilitation period. All of these are of paramount importance in an active young individual for an earlier return to routine / sporting activity.

The above case report is one of the many examples of Revision Bankart where we chose to go in for a revision Arthroscopic procedure after a thorough pre-operative evaluation and planning. Clinical experience coupled with surgical expertise and access to state-of-the-art technology can shift the balance in the patient's favour to provide reliable and superior outcomes.

FIXED FOR GOODExpert correction of recurrent Shoulder Dislocation

Dr. Deepak ChaudharyDirectorArthroscopy and Sports Medicine Centre BLK Super Speciality Hospital, New Delhi

An active 51-year-old left-hand dominant gentleman was brought to BLK Super Speciality Hospital with a history of recurrent left shoulder dislocation. The patient had a long-standing history of left shoulder instability for which he underwent an Arthroscopic Bankart Repair in some other hospital in the year 2005. However, following a year after the procedure, the patient had recurrent episodes of left shoulder dislocation. He visited multiple centres and was advised an Open Latarjet Surgery for recurrent anterior instability of his left shoulder. He further consulted the expert team at Arthroscopy and Sports Medicine Centre, BLK Hospital.

On clinical examination, the patient had tenderness and terminally restricted range of motion in his left shoulder. The Apprehension test was positive, characteristic of anterior shoulder instability. Radiographs and Magnetic Resonance Images (MRI) revealed a large Hill Sachs lesion and a soft tissue Bankart lesion. The experts at BLK, hence, concluded that failure of the initial procedure was due to re-injury leading to mechanical failure. After examining the job profile of the patient and activity level, the treatment options were discussed with the patient. With his consent, the team decided to go ahead with Arthroscopic evaluation and a definitive plan of either Revision

04 Radiant Life Care | Newsletter | October 2018 05BLK, New Delhi | Nanavati, Mumbai

"The Bankart lesion is one of the common soft tissue injuries of the shoulder involving a tear in the anterior inferior Glenoid labrum due to anterior shoulder dislocation."

ENHANCEDMANAGEMENTUro-oncology – a leading-edge field for the treatment of Prostate, Kidney, Bladder and Testicular Cancers

Dr. Vivek VenkatConsultant Uro-oncologist & Robotic Urologist Nanavati Super Speciality Hospital Mumbai

Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like prostate, kidney and urinary bladder cancer. A rapid pace of research with new developments every day makes this a very exciting field.

Advances in Prostate CancerProstate Cancer is the commonest Cancer among western men and is becoming very common in India as well. International health agencies recommend annual PSA screening in men aged 50-70 years to detect Prostate Cancer early, however, this resulted in the diagnosis of low-grade cancers which may not affect the patient’s life. With an understanding of this natural history, specific tests to detect aggressive cancers were developed. Utilising PSA-derivatives and related molecules, newer tests like the 4-K Score (PSA, free-PSA, intact-PSA and HK-2) and the Prostate Health Index (PSA, f-PSA and -2-pro PSA) developed excellent accuracy for the detection of aggressive Prostate Cancer. These tests are used routinely abroad and are gradually being introduced in India. Multiparametric MRI of the prostate has revolutionised prostate imaging with excellent accuracy for aggressive Prostate Cancer. Using MRI to guide biopsies can reduce the detection of harmless cancers by 30% and increase the detection of aggressive cancers by 15%.

Advances in Kidney CancerPartial Nephrectomy (PN) to conserve renal function has been the gold standard for renal masses <4cm. Recent studies have shown the oncologic safety of this

approach even for tumours up-to 7cm and recent guidelines recommend whenever possible. This is crucial given the rampant nature of Diabetes and Hypertension in India, diseases which can also affect renal function. With the robotic platform, surgeons have a truly minimally-invasive alternative to tackle complex tumours with reduced bleeding, quicker recovery and comparable ischemia times to open surgery. Medications targeting vascular growth factors have truly changed the management of metastatic disease allowing prolonged responses in many patients and sometimes making unresectable Tumours operable.

Advances in Bladder CancerRadical Cystectomy for Invasive Bladder Cancer remains a complicated procedure. The RAZOR trial was published in The Lancet in June 2018 which showed that Robotic Cystectomy has comparable Oncologic outcomes, less bleeding and shorter hospital stay than Open Cystectomy. It was the world’s first multicenter randomised trial comparing robotic to open surgery for any organ site. Refinements in the technique now allow us to perform urinary diversions intracorporeally with the robot – a truly minimally-invasive approach.

"Uro-oncology is devoted to the diagnosis and treatments of tumours of urinary systems. Most importantly, taking care of patients with prostate cancer, kidney, testicular and bladder cancer."

Dr. Shiv Chouksey Associate Consultant Arthroscopy and Sports Medicine Centre BLK Super Speciality Hospital, New Delhi

Post operative X-ray image

Page 4: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

There are numerous advantages of Robotic surgery which include 3D HD vision, 7 degrees of freedom, more precision and control, meticulous dissection, better ergonomics, improved dexterity, endo-wrist movements, 10X magnification and greater instrument stability. Robotic-assisted surgery is expanding the capabilities of surgery and is changing the face of medical care. With the development of Robotic technology, surgeons can offer minimally invasive procedures in place of certain open procedures, which involve increased risk of possible side effects. It enables surgeons to perform a variety of delicate and complicated surgical procedures with improved outcomes. These are some of the reasons

why, BLK Cancer Centre decided to equip itself with the latest acquired technology -the Da Vinci Xi Robot,

EMBARKING ON THE ROBOTIC ODYSSEYRobotic Total Gastrectomy and Roux-en-Y Esophagojejunostomy

Om Prakash, a 77-year-old septuagenarian, was brought to BLK Cancer Centre with complaints of difficulty in swallowing for the past 2 months, accompanied with a significant weight loss. On evaluation, he was diagnosed to have poorly differentiated Adenocarcinoma of the stomach involving fundus and the body of the stomach along the lesser curvature extending on to the GE junction. After a comprehensive evaluation, the patient was counselled for surgical resection.

Dr. Surender Dabas and his team planned and performed a Robotic Total Gastrectomy upon the patient with distal Pancreatectomy, Splenectomy and Roux-en-Y Esophagojejunostomy with feeding Jejunostomy on 12 September 2018. This was a historic moment for BLK as it was the first-of-its-kind surgery ever performed at

the hospital. This Robotic procedure required extensive resection. It would have required a Laparotomy with a big midline abdominal wound, delayed recovery and greater morbidity to the patient, if it had been done by conventional open surgery. Robotic Surgery, on the other hand, has the advantage of having fewer overall complications, lesser blood loss, reduced post-operative pain, early recovery and shorter hospital stay

The operation was uneventful, and the patient had an excellent post-operative recovery with no complications. Gastrograffin study on the 7th post-operative day revealed no anastomotic leak and the patient was started on oral feeds. On discharge, both the patient and the attendants expressed satisfaction with the surgery and post-operative outcome.

Dr. Surender DabasDirector – Surgical Oncology & Chief – Robotic SurgeryBLK Cancer Centre BLK Super Speciality Hospital, New Delhi

which is the most advanced Robotic system approved for human use offering Robotically-assisted enhanced services.

The newly upgraded Centre has also benefitted greatly by the joining of well-accomplished Oncologist Dr. Surender Kumar Dabas, who also happens to be an esteemed pioneer of TransOral Robotic Surgery in India, to spearhead the Robotic Surgery Program at BLK Hospital. He has joined BLK Hospital as the Chief of Robotic Surgery and Director of Surgical Oncology Department. Dr. Dabas is credited with the maximum number of TransOral Robotic Surgeries in Asia and has already performed more than 20 challenging Robotic surgeries including Robotic Total Gastrectomy, Lung Bilobectomy, Radical Prostatectomy, Radical Hysterectomy, Partial & Radical Nephrectomy and TransOral Robotic surgeries at BLK. With the recent upgrades and a comprehensive Robotic program, expertly manned by top specialists, BLK Cancer Centre now joins the ranks of select institutions in the country to offer highly complicated and sophisticated Robotic surgeries.

06 Radiant Life Care | Newsletter | October 2018 07BLK, New Delhi | Nanavati, Mumbai

"The da Vinci Surgical System enables surgeons to attain a three-dimensional surgical view, instrument flexibility, tremor suppres-sion, and improved ergo-nomics. It allows the sur-geon to explore a different part of the body mid-oper-ation without repositioning the entire apparatus."

“Robotic surgery is a type of minimally invasive surgery that allows a surgeon to perform many types of complex procedures with more precision, flexibility and control than is possible with conventional techniques.

Da Vinci Xi Robot

Dr. Surender Dabas and Dr. Ashwani Sharma with the patient post the

successful surgery

PRECISION MEETS TECHNOLOGY

Page 5: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

Spinal Cord Stimulation is a therapy that masks pain signals before they reach the brain. A small device called the Spinal Cord Stimulator is implanted in the body for the same.

How It Works: Spinal Cord Stimulation is based on the gate control theory of pain proposed by Wall and Melzack. Pain is felt because nerves send the pain signal to the brain. This pain transmission occurs through the ‘gate’ in substantia gelatinosa in the dorsal aspect of the spinal cord. At the gate, both myelinated fibre (which transmits pressure, touch and vibration) and unmyelinated fibres (which transmits pain) try to pass messages through the synapse. However, through the gate, only one message can pass through at a time; either through myelinated fibres or unmyelinated fibres. The message through myelinated fibres is preferred over unmyelinated ones.

Spinal Cord Stimulator is a small device implanted inside the body (like a pacemaker), which has a pulse generator with a battery and thin wires called ‘leads”. It is operated through an external hand-held remote control. When the patient feels pain, he presses the remote, electrical pulses are generated which are carried by leads to the spinal cord that blocks the pain signals through the ‘gate’ travelling to the brain. Instead of pain, the patient feels a vibration/fluttering sensation that replaces the pain. Stimulation does not eliminate the source of pain, it simply interferes with the signal to the brain, and so the amount of pain relief varies for each person.

BID FAREWELL TO PAINSpinal Cord Stimulator – A boon for patients with pains of Neuropathic origin

Indications: Spinal Cord Stimulation is particularly effective for relieving the pain of neuropathic origin. The most common indications include – Failed Back Surgery Syndrome (FBSS)

with radicular pain Complex Regional Pain Syndrome (CRPS) Cervical and Lumbar Radiculopathy Arachnoiditis Peripheral Neuropathy Intractable pain from Postherpetic

Neuralgia Phantom Limb pain Ischemic Limb pain

The Surgical Process: Implantation of the Spinal Cord Stimulator is a two-step process. Since the amount of pain relief varies for each person and some patients find the tingling sensation unpleasant, a trial stimulation is performed before the device is permanently implanted.

Stage 1. Trial Spinal Cord Stimulation: Trial stimulation is a "test drive" to determine if a Spinal Cord Stimulator will work for the type, location, and severity of the pain. It is performed under local anaesthesia. Using X-ray, a hollow needle is inserted through the skin into the epidural space between the bone and spinal cord. The trial lead is inserted and positioned over specific nerves. The wires are attached to an external generator worn on a belt. After 4 to 7 days, the decision to permanently implant the stimulator is taken based on the improvement in pain.

Stage 2. Permanent Spinal Cord Stimulation: If the trial is successful and there is greater than 50% improvement in pain, surgery can be scheduled to permanently implant the Spinal Cord Stimulator. The Spinal Cord Stimulator will be placed in the body, depending on the site of pain. For Chest wall common lead placement target is T1-T2, for Back and Legs T7-T9, for legs T10, and for pelvis L1.

08 Radiant Life Care | Newsletter | October 2018 09BLK, New Delhi | Nanavati, Mumbai

Dr. Purushottam VashisthaConsultant Gastroenterologist & Hepatologist Nanavati Super Speciality Hospital Mumbai

Recently a young man of 32 years came to Nanavati Super Speciality Hospital with distension of the abdomen and Jaundice since the past 2 weeks along with abnormal sensorium. He had a long history of about 20 years of consultations with other Gastroenterologist in the past. He was diagnosed with extrahepatic portal venous obstruction. There was no history of ascites or appearance of Jaundice.

The patient had undergone Ogd and EVL several times in the past. Examination showed he had tense ascites along with deep icterus and little incoherence. On evaluation, he was found to have 3.5 cms SOL in the right lobe of the liver with Cirrhosis. The patient was found to be negative for serology and other treatable causes of Cirrhosis. Based on Milan’s criteria, he was advised for Liver Transplantation as a curative treatment.

He was evaluated for a Liver Transplant; however, during the course of the evaluation, he developed Sepsis (Staphylococcus in the blood) and SBP and Coagulopathy along with severe Hemolysis (DCT positive 3+) a Paraneoplastic Syndrome feature. The patient's condition improved with antibiotics and high doses of steroid as advised by our Haematologist but was instituted to lower doses for fear of recurrent SBP or fungal Sepsis. The patient improved over a couple of days.

EHPVO patients only have Variceal Bleed as the first presentation without any ascites, icterus or encephalopathy and they need repeated EVL and close follow up. They behave like compensated CLD and also have coarse echotexture on USG. To differentiate between Cirrhosis and EHPVO, FibroScan or MR Elastography or liver biopsy in some equivocal cases should be used.

Initially, the patient did not have any ascites, deep Jaundice or Encephalopathy and these compensated statuses were misinterpreted as EHPVO disease. The patient decompensated for the first time with the appearance of ascites, mild encephalopathy and jaundice. Any sudden decompensation in patients suspected with CLD is a clue for HCC or PVT. Being a Gastroenterologist, our goal is to prevent the development of Cirrhosis in any Chronic Hepatitis. Patient care and proper surveillance of Cirrhotic patients is vital to check the development of HCC.

Hepatocellular Carcinoma (HCC) is a primary malignancy of the liver and occurs predominantly in patients with underlying chronic liver disease and Cirrhosis. Presentation of HCC is now increasingly recognised at a much earlier stage in comparison to the past as a consequence of the routine screening of patients with known cirrhosis using cross-sectional imaging studies.

There is also a growing problem with Cirrhosis, which develops in the setting of Non-alcoholic Fatty Liver Disease (NAFLD), or Non-alcoholic Steatohepatitis (NASH). NASH patients have more chances of developing HCC in comparison to ALD or other causes of Cirrhosis and needs stringent surveillance programme.

HCC IS NOW THE THIRD LEADING CAUSE OF CANCER DEATHS WORLDWIDE, WITH OVER 500,000 PEOPLE AFFECTED.The incidence of HCC is highest in Asia and Africa, where the endemic high prevalence of HEPATITIS B AND HEPATITIS C STRONGLY PREDISPOSES TO THE DEVELOPMENT of chronic liver disease and subsequent development of HCC.

Chronic pain is a leading cause of physical and emotional suffering, familial and social disruptions, disability and work absenteeism. Neuromodulation with Spinal Cord Stimulation is one of the most exciting developments in chronic pain management. We have successfully treated two patients with Spinal Cord Stimulators at BLK Super Speciality Hospital.

A point to note here is that he had been examined by several Physicians and Gastroenterologist, but was never evaluated for Cirrhosis which is a pre-malignant condition.

Dr. Puneet GirdharDirector – Spine SurgeryBLK Centre for Orthopae-dics, Joint Reconstruction & Spine SurgeryBLK Super Speciality Hospital, New Delhi

Dr. Rohit GulatiConsultant – Pain ManagementBLK Super Speciality Hospital, New Delhi

THE RIGHT WAYExpert intervention helps patient with a 3.5 cms SOL in the right lobe of the Liver with Cirrhosis

Page 6: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

FACE-OFF WITH A SURGING CONDITIONFacial symmetry restored in a 64-year-old patient with a gradually progressive left facial swelling

A 64-year old man with painless left facial swelling, which was gradually progressing for the past one year, was brought to Nanavati Super Speciality Hospital. The swelling was causing fluid discharge and redness in the left eye since the last 2 months and was also slowly developing double vision. On examination, there was a diffused bony swelling under the left cheek approx 10cmx 10cm in size, hard, fixed, non-tender, with normal overlying skin. Intraorally there was a bulge of the hard palate, occupying a large area of the oral cavity.

A CECT (Contrast Enhanced Computed Tomography) scan of the paranasal sinuses and neck showed a well defined lobulated soft tissue 10x8x6cm sized lesion. The lesion was seen arising from the ethmoid sinus medial wall with erosion, intraorbital extension, extending into the caudal aspect of the left infratemporal fossa, left retromolar trigone, involving the left masseter muscle, left temporalis muscle, flushed with the left medial rectus muscle, left zygomatic bone and left maxillary annulus.

CT guided Tru-cut biopsy from the left cheek swelling showed Benign Fibro-osseous Lesion, suggestive of Cemento-ossifying Fibroma.

The patient was planned for a left maxillectomy with reconstruction. A stony hard mass of 10cm x 8cm x 6cm size was removed en bloc and reconstruction was done with microvascular anterolateral thigh flap transfer. The post-operative period was uneventful, and the patient was discharged within a week with all vitals under normal limits. He was taking food orally and was well mobilised. HPE report showed Cemento- ossifying fibroma.

Cemento-ossifying Fibroma is a relatively rare non-odontogenic Tumour of jaws. Cememto-ossifying Fibroma now called as Ossifying Fibroma are odontogenic which originates from the periodontal ligament or from an ectopic periodontal membrane in the frontal, temporal, sphenoid and ethmoid bones. These are slow growing Tumours and if neglected may lead to facial asymmetry due to cortical expansion. Complete and thorough surgical removal at the earliest is advised and 10 years follow-up is required. Large Tumour of the facial skeleton can be severely debilitating for form and function in term of cosmetic deformity and difficulty in speech and swallowing.

10 Radiant Life Care | Newsletter | October 2018 11BLK, New Delhi | Nanavati, Mumbai

GOOD TO KNOW FACTSThings worth knowing to have a good understanding of Tuberculosis of the Lymph Node

Dr. Salil S. BendreConsultant Pulmonologist & BronchoscopistNanavati Super Speciality Hospital Mumbai

What causes Tuberculosis (TB) of the Lymph Node? Tuberculosis is an infectious disease. It spreads through inhalation of bacteria. Once the bacteria enter the lungs, they lodge in the Lymph Nodes of the lung. They may remain there for a variable duration in the form of latent or dormant bacteria.

Whenever the immunity drops down like in the case of diabetes, HIV, malnutrition etc. can these dormant bacteria become active and give rise to disease in the form of enlarged Tuberculosis lymph nodes?Yes, Tuberculosis can cause enlarged or swollen Lymph Nodes either in the respiratory system or any other part of the body.

What are the symptoms of Lymph Node Tuberculosis?The symptoms will depend on the site of involvement of the disease. If the neck Lymph Nodes are enlarged, it will give rise to a swelling in the neck which may be painful. Fever and weight loss usually accompany these nodes. There may be pus formation within the Lymph Nodes. At times, the nodes may rupture with the release of the pus.

Is Lymph Node Tuberculosis infectious?Lymph Node Tuberculosis doesn't get transmitted from person to person. However, if the patient also has lung Tuberculosis, then he or she may transmit the infection to others by coughing.

Can you get Lymph Node Tuberculosis by drinking raw milk

from infected cattle?The possibility is high as Mycobacterium Bovis is transmitted through the raw milk of infected cattle.

Can TB come back after treatment?Yes, Tuberculosis can relapse or recur after treatment. This happens because the dormant or latent Tuberculosis bacteria can get reactivated anytime in life. Whenever the immunity becomes inadequate, there is a high risk of relapse or recurrence of Tuberculosis. Common reasons for this are Diabetes, HIV, steroids, anaemia, malnutrition.

What are the side effects of TB treatment?Side effects of TB treatment are specific to the drugs used: Hepatitis, nausea, jaundice, vomitting is seen with Isoniazid, Rifampicin, Pyrazinamide Visual disturbances are because of Ethambutol toxicity Joint pains because of increased uric acid occurs because of Pyrazinamide Streptomycin can lead to ototoxicity, giddiness, vertigoHowever, not all patients develop side effects.

Dr. Sudeep SarkarSr. ConsultantSurgical OncologyNanavati Super Speciality Hospital Mumbai

Pre & Post-surgery images CT Scan

"These are slow growing tumours and if neglected may lead to facial asymmetry due to cortical expansion. Complete and thorough surgical removal at the earliest is advised, and 10 years follow-up is required."

"Tuberculosis can cause enlarged or swollen Lymph Nodes either in the Respiratory System or any other part of the body."

Page 7: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

12 Radiant Life Care | Newsletter | October 2018 13BLK, New Delhi | Nanavati, Mumbai

EVENTS AND ACTIVITIES

WELCOME TO BLK!Eminent Oncologist and an esteemed pioneer of Trans-oral Robotic Surgery in India, Dr. Surender Kumar Dabas has joined BLK Hospital as Chief of Robotic Surgery and Director of Surgical Oncology Department. He has been actively involved in teaching Robotic Surgery across India and is credited with the maximum number of Robotic Head and Neck Surgery performed in Asia.

He was previously associated with Rajiv Gandhi Cancer Hospital as Head of Unit, Head/Neck Oncology and Robotic Surgery and as Director, Surgical Oncology at Fortis Memorial Research Institute. With more than 15 years of experience in Surgical Oncology, Dr. Dabas has a key interest in Head and Neck Oncology, TransOral Robotic Surgery, Robotic GI Surgery, Thoracic Surgery and Gynaecological Surgery.

Jet Airways expressed their sincere gratitude towards Dr. Sandeep Nayar, HOD, BLK Centre for Chest & Respiratory Diseases, BLK Super Speciality Hospital for his timely medical assistance aboard their flight. On 22nd September, 2018 when one of the passengers fell unconscious during the Delhi-Mumbai flight, Dr. Nayar immediately gave the passenger First Aid and helped him regain his consciousness. He continued to monitor the patient during rest of the flight. Fortunately, thanks to Dr. Nayar's prompt and compassionate action the passenger regained full consciousness and was in a safe condition when the flight landed.

Munish Dev, the first Indian to finish the world's most difficult La Ultra Marathon, recently visited the Centre for Arthroscopy & Sports Medicine at BLK Super Speciality Hospital. L to R: Dr. Shiv Chouksey, Dr. Deepak Chaudhary, Mr. Munish Dev and members of the hospital management team.

HEALTHCARE PARTNER FOR IDBI MARATHON 2018

CAMP IN OMAN

Nanavati Super Specialty Hospital was the official Medical partner for IDBI Half Marathon 2018 organized on 30th September 2018 at Bandra Kurla Complex. The marathon was flagged off by Sachin Tendulkar and witnessed over 15000 participants. This was the second consecutive year of Nanavati's association with IDBI Marathon.

Nanavati had participated in 8th Oman Health Exhibition, an International trade event organised by Federation of Indian Chambers of Commerce and Industry (FICCI) from 23-27 September, 2018 at Oman Convention and Exhibition Centre, Muscat, Oman. More than 76 patients were counselled for Spine, Neurosurgery, Cardiology & Bone Marrow Transplant. The exhibition was followed by a Business Association Meeting at the Indian Embassy, Oman.

A TOKEN OF GRATI-TUDE!

Page 8: Embarking on THE ROBOTIC ODYSSEY - India - Nanavati …Speciality Hospital Mumbai Uro-oncology is a specialised, cutting-edge branch of Urology which includes very common cancers like

14 Radiant Life Care | Newsletter | October 2018 15BLK, New Delhi | Nanavati, Mumbai

BLK AND NANAVATI IN NEWS